EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 22004D0023

Decision of the EEA Joint Committee No 23/2004 of 19 March 2004 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

OJ L 127, 29.4.2004, p. 128–129 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)

This document has been published in a special edition(s) (CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO, HR)

Legal status of the document In force

ELI: http://data.europa.eu/eli/dec/2004/23(2)/oj

22004D0023

Decision of the EEA Joint Committee No 23/2004 of 19 March 2004 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

Official Journal L 127 , 29/04/2004 P. 0128 - 0129


Decision of the EEA Joint Committee

No 23/2004

of 19 March 2004

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as "the Agreement", and in particular Article 98 thereof,

Whereas:

(1) Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 3/2004 of 6 February 2004(1).

(2) Commission Directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use(2) is to be incorporated into the Agreement.

(3) Directive 2003/94/EC repeals Commission Directive 91/356/EEC(3), which is incorporated into the Agreement and which is consequently to be repealed under the Agreement,

HAS DECIDED AS FOLLOWS:

Article 1

Chapter XIII of Annex II to the Agreement shall be amended as follows:

1. The following point shall be inserted after point 15s (Commission Regulation (EC) No 1085/2003):

"15t. 32003 L 0094: Commission Directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use (OJ L 262, 14.10.2003, p. 22)."

2. The text of point 15 (Commission Directive 91/356/EEC) shall be deleted.

Article 2

The texts of Directive 2003/94/EC in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 20 March 2004, provided that all the notifications pursuant to Article 103(1) of the Agreement have been made to the EEA Joint Committee(4).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 19 March 2004.

For the EEA Joint Committee

The President

P. Westerlund

(1) OJ L 116, 22.4.2004, p. 44.

(2) OJ L 262, 14.10.2003, p. 22.

(3) OJ L 193, 17.7.1991, p. 30.

(4) No constitutional requirements indicated.

Top